戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s isolated from a cow with infectious bovine keratoconjunctivitis.
2 stically significant risk factors for vernal keratoconjunctivitis.
3  year after surgery to monitor the status of keratoconjunctivitis.
4 al visual outcome in cases of microsporidial keratoconjunctivitis.
5 , gastroenteritis, hemorrhagic cystitis, and keratoconjunctivitis.
6 dependent/resistant cases of severe allergic keratoconjunctivitis.
7 addition to treatment of epidemic adenoviral keratoconjunctivitis.
8 ients has been reported to suffer from acute keratoconjunctivitis.
9 sfunctional tear syndrome (n = 9) and atopic keratoconjunctivitis (9).
10 V-37) is a major etiologic agent of epidemic keratoconjunctivitis, a common and severe eye infection
11              Similar to other forms of toxic keratoconjunctivitis, a detailed history and careful cli
12 genotypes within HAdV species D and epidemic keratoconjunctivitis, a severe ocular surface infection.
13 tients affected with vernal (VKC) and atopic keratoconjunctivitis (AKC) was investigated to identify
14  prevalence and associated factors of vernal keratoconjunctivitis among children living in Gondar Cit
15               The association between vernal keratoconjunctivitis and factors such as socio-economic,
16 spectively) are causative agents of epidemic keratoconjunctivitis and genital tract infections.
17                              Superior limbic keratoconjunctivitis and lagophthalmos are prognostic ma
18 63 patients clinically diagnosed with vernal keratoconjunctivitis and shield ulcers.
19 63 patients clinically diagnosed with vernal keratoconjunctivitis and shield ulcers.
20 such as keratoconjunctivitis sicca, allergic keratoconjunctivitis, and corneal allograft rejection.
21 t across atopic keratoconjunctivitis, vernal keratoconjunctivitis, and perennial AC groups.
22 ptomatic atopic keratoconjunctivitis, vernal keratoconjunctivitis, and perennial AC, and who had hist
23 ncluding ocular cicatrial pemphigoid, vernal keratoconjunctivitis, and pterygium.
24  37 (Ad37), a virus associated with epidemic keratoconjunctivitis, but not a closely related virus se
25                        Outbreaks of epidemic keratoconjunctivitis (EKC) are costly in terms of produc
26 ance system revealed an increase of epidemic keratoconjunctivitis (EKC) from an average of 320 cases/
27 (HAdV-D19) has been associated with epidemic keratoconjunctivitis (EKC), a highly inflammatory infect
28 ludes those viruses associated with epidemic keratoconjunctivitis (EKC), a severe ocular surface infe
29 Moreover, the animals were protected against keratoconjunctivitis following conjunctival challenge wi
30 and associated comorbidities (such as vernal keratoconjunctivitis, further compromising ocular health
31 types of EGFRi-associated keratitis included keratoconjunctivitis (HR, 1.367; 95% CI, 1.158-1.615), s
32 rokeratoconjunctivitis (BKC), herpes simplex keratoconjunctivitis (HSK), or vernal keratoconjunctivit
33 date for a vaccine against infectious bovine keratoconjunctivitis (IBK) has been cloned and character
34                            Infectious Bovine Keratoconjunctivitis (IBK) in beef cattle, commonly know
35                            Infectious bovine keratoconjunctivitis (IBK) is a highly contagious ocular
36  of the mouse intestine and expressed severe keratoconjunctivitis in guinea pigs.
37 pe 37 (Ad37), a subgroup D virus that causes keratoconjunctivitis in humans, does not infect cells vi
38         There is a high prevalence of vernal keratoconjunctivitis in this region.
39  of an inflammatory cytokine associated with keratoconjunctivitis, interleukin-1beta (P = 0.025), in
40                                 The lacrimal keratoconjunctivitis (LKC) was mediated by CD4(+) T cell
41 directed against shigellosis, the guinea pig keratoconjunctivitis model was used to evaluate the adju
42                                 Guinea pigs (keratoconjunctivitis model) or mice (lethal lung model)
43                            In the guinea pig keratoconjunctivitis model, a Shigella pic mutant induce
44 and protective efficacy using the guinea pig keratoconjunctivitis model.
45 immunogenic and protective in the guinea pig keratoconjunctivitis model.
46  (atopic keratoconjunctivitis n = 13, vernal keratoconjunctivitis n = 1, perennial AC n = 16), 87% of
47        Thirty patients were enrolled (atopic keratoconjunctivitis n = 13, vernal keratoconjunctivitis
48  the Quality of Life in Children with Vernal Keratoconjunctivitis questionnaire) improved in all 3 gr
49 to be more susceptible to developing chronic keratoconjunctivitis (rs1478604: odds ratio [OR], 2.5; 9
50 challenge with wild-type S. flexneri 2a in a keratoconjunctivitis Sereny test.
51       The commonest ocular manifestation was keratoconjunctivitis sicca (11.3%) followed by blepharit
52 ues, resulting in xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes).
53 to generate an inducible autoimmune model of keratoconjunctivitis sicca (KCS) for study of pathogenes
54 une; Sandoz, Basel, Switzerland) in treating keratoconjunctivitis sicca (KCS) include an effect on th
55                                              Keratoconjunctivitis sicca (KCS) is characterized by inf
56 ta, and MMP-9, similar to that seen in human keratoconjunctivitis sicca (KCS) or "dry eyes." Therefor
57  surface epithelial changes resembling human keratoconjunctivitis sicca (KCS) that are exacerbated by
58 initiating inflammatory responses leading to keratoconjunctivitis sicca (KCS), autoimmunity, and Sjog
59 genesis of goblet cell deficiency-associated keratoconjunctivitis sicca (KCS, or dry eye).
60  control subjects (C), 73 with non-Sjogren's keratoconjunctivitis sicca (non-SS KCS) and 21 with Sjog
61 ssment of 210 people, 130 with non-Sjogren's keratoconjunctivitis sicca (non-SS KCS), 32 with Sjogren
62 s may play a key role in the pathogenesis of keratoconjunctivitis sicca and may be a therapeutic targ
63 mmon autoimmune rheumatic disease, refers to keratoconjunctivitis sicca and xerostomia resulting from
64  autoimmune disease that is characterized by keratoconjunctivitis sicca and xerostomia resulting from
65 ropean Americans) that typically presents as keratoconjunctivitis sicca and xerostomia.
66 bow/hip dysplasia before osteoarthritis, and keratoconjunctivitis sicca before corneal ulcer, which a
67 xperimental dry eye models and patients with keratoconjunctivitis sicca due to the induction of inter
68 degeneration, neuroophthalmic disorders, and keratoconjunctivitis sicca in patients with HTLV-1-assoc
69 p in our understanding of the dacryoadenitis/keratoconjunctivitis sicca in this model.
70                                              Keratoconjunctivitis sicca is a common ocular surface di
71 ces in pathogenesis include the concept that keratoconjunctivitis sicca is a condition of abnormal gr
72                 These findings indicate that keratoconjunctivitis sicca may represent a chronic wound
73                                              Keratoconjunctivitis sicca or dry eye disease (DED) is a
74                                              Keratoconjunctivitis sicca was induced bilaterally in si
75  are extreme tiredness, along with dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia).
76 the immunopathogeneses of conditions such as keratoconjunctivitis sicca, allergic keratoconjunctiviti
77                                    IgG, IgA, keratoconjunctivitis sicca, and sex, identified as the b
78 eatures of ocular graft versus host disease (keratoconjunctivitis sicca, cicatricial conjunctivitis,
79 to investigate autoimmune dacryoadenitis and keratoconjunctivitis sicca, features of SS.
80 s which included failed bleb, corneal edema, keratoconjunctivitis sicca, filamentary keratitis, corne
81                      Ocular findings include keratoconjunctivitis sicca, pseudomembranous conjunctivi
82 e implant was effective in a canine model of keratoconjunctivitis sicca, with all animals able to dis
83 vide insight into the immune pathogenesis of keratoconjunctivitis sicca.
84 d efficacy in a clinically relevant model of keratoconjunctivitis sicca.
85  canine model of aqueous tear deficiency and keratoconjunctivitis sicca.
86 enatal death, vulva and clitoral defects and keratoconjunctivitis sicca.
87 moderate to severe dry eye disease caused by keratoconjunctivitis sicca.
88 ocular surface inflammation that mimic human keratoconjunctivitis sicca.
89 1 may play a key role in the pathogenesis of keratoconjunctivitis sicca.
90 ations, including inflammatory arthritis and keratoconjunctivitis sicca.
91                                   The VErnal KeratoconjunctiviTIs Study (VEKTIS) is a phase 3, multic
92 ) initially randomized in the 4-month VErnal KeratoconjunctiviTIs Study (VEKTIS), 142 entered the 8-m
93                                       Vernal keratoconjunctivitis symptoms and patient QoL (assessed
94 novirus type 19 is a major cause of epidemic keratoconjunctivitis, the only ocular adenoviral infecti
95 inical presentation consistent with epidemic keratoconjunctivitis (type 37 [n = 6], 8 [n = 4], 4 [n =
96 owing were positively associated with vernal keratoconjunctivitis: use of kerosene/firewood for cooki
97 ts with chronic, severely symptomatic atopic keratoconjunctivitis, vernal keratoconjunctivitis, and p
98  CI, -76% to -31%), consistent across atopic keratoconjunctivitis, vernal keratoconjunctivitis, and p
99                                       Vernal keratoconjunctivitis (VKC) and eye rubbing may be associ
100            Understanding and treating vernal keratoconjunctivitis (VKC) has been a challenge because
101 appropriate eye care in children with vernal keratoconjunctivitis (VKC) in Rwanda (Central Africa).
102                                       Vernal keratoconjunctivitis (VKC) is a chronic, allergic, and p
103                                       Vernal keratoconjunctivitis (VKC) is a common cause of ocular m
104                                       Vernal keratoconjunctivitis (VKC) is a severe ocular allergy wi
105                                       Vernal keratoconjunctivitis (VKC) is a severe type of allergic
106 implex keratoconjunctivitis (HSK), or vernal keratoconjunctivitis (VKC) were included.
107 ng from Down syndrome associated with vernal keratoconjunctivitis (VKC), a rare disorder of the anter
108 available in chronic atopic (AKC) and vernal keratoconjunctivitis (VKC), the pathophysiology of which
109 68 of 116 eyes (58.6%) had associated vernal keratoconjunctivitis (VKC).
110 ds of patients (59.0%; p = 0.33) with vernal keratoconjunctivitis (VKC).
111                     The prevalence of vernal keratoconjunctivitis was 5.8 % (95 % CI: 4.14, 7.53) (43
112 s of 14 healthy patients with microsporidial keratoconjunctivitis were diagnosed based on the detecti
113 res suggestive of microsporidial superficial keratoconjunctivitis were included in the study.
114 on, suggestive of microsporidial superficial keratoconjunctivitis, were included in the prospective s
115 requently reported ocular manifestations are keratoconjunctivitis with dry eye and retinal degenerati
116 animals were significantly protected against keratoconjunctivitis (zero of eight vaccinees versus fiv

 
Page Top